bevacizumab

Spain

Drugs containing this active substance

  • ABEVMY 25 MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION

    It is used to treat several types of cancer in adults, including advanced colon or rectal cancer, metastatic breast cancer, advanced non-small cell lung cancer, advanced renal cancer, primary epithelial ovarian, fallopian tube, or peritoneal cancer, and persistent, recurrent, or metastatic cervical cancer.

    Form: solution for infusion, concentrate

    Active substance Dosage
    bevacizumab 25 mg/ml

    ATC: L01F L01FG L01FG01

    Manufacturer: Biosimilar Collaborations Ireland Limited

  • It is used to treat various types of cancer in adults, including advanced colon or rectal cancer, metastatic breast cancer, advanced non-small cell lung cancer, advanced renal cancer, primary epithelial ovarian, Fallopian tube, or peritoneal cancer, and persistent, recurrent, or metastatic cervical cancer.

    Form: solution for infusion, concentrate

    Active substance Dosage
    bevacizumab 100 mg

    ATC: L01F L01FG L01FG01

    Manufacturer: Mabxience Research S.L.

  • It is used to treat several types of cancer in adults, including advanced colon or rectal cancer, metastatic breast cancer, advanced non-small cell lung cancer, advanced renal cancer, primary epithelial ovarian, fallopian tube, or peritoneal cancer, and persistent, recurrent, or metastatic cervical cancer.

    Form: solution for infusion, concentrate

    Active substance Dosage
    bevacizumab 25 mg

    ATC: L01F L01FG L01FG01

    Manufacturer: Roche Registration Gmbh

  • It is used to treat several types of cancer in adults, including advanced colon or rectal cancer, metastatic breast cancer, advanced non-small cell lung cancer, advanced renal cancer, primary epithelial ovarian, fallopian tube, or peritoneal cancer, and persistent, recurrent, or metastatic cervical cancer.

    Form: solution for infusion, concentrate

    Active substance Dosage
    bevacizumab 25 mg

    ATC: L01F L01FG L01FG01

    Manufacturer: Roche Registration Gmbh

  • It is used to treat several types of cancer in adults, including advanced colon or rectal cancer, metastatic breast cancer, advanced non-small cell lung cancer, advanced renal cancer, primary epithelial ovarian, fallopian tube, or peritoneal cancer, and persistent, recurrent, or metastatic cervical cancer.

    Form: solution for infusion, concentrate

    Active substance Dosage
    bevacizumab 25 mg/ml

    ATC: L01F L01FG L01FG01

    Manufacturer: Samsung Bioepis Nl B.V.

  • It is used to treat adult patients with various types of cancer, including advanced colon or rectal cancer, metastatic breast cancer, advanced non-small cell lung cancer, advanced renal cancer, primary epithelial ovarian, fallopian tube, or peritoneal cancer, and persistent, recurrent, or metastatic cervical cancer.

    Form: solution for infusion, concentrate

    Active substance Dosage
    bevacizumab 100 mg

    ATC: L01F L01FG L01FG01

    Manufacturer: Amgen Technology (Ireland) Unlimited Company

  • What type of cancer is MVASI prescribed for?": "It is used to treat adults with advanced colon or rectal cancer, metastatic breast cancer, advanced non-small cell lung cancer, advanced renal cancer, primary epithelial ovarian, fallopian tube, or peritoneal cancer, and persistent, recurrent, or metastatic cervical cancer.", "How should MVASI be administered?": "It is administered via intravenous infusion (drip into the veins) performed by a doctor or nurse. The dose depends on the patient's weight and is applied once every 2 or 3 weeks.", "When should this medicine not be used?": "It should not be used if you are allergic to bevacizumab or its components, if you are allergic to products derived from Chinese hamster ovary cells or other similar antibodies, or if you are pregnant.", "What side effects can MVASI cause?": "It may cause frequent side effects such as high blood pressure, fatigue, diarrhea, nausea, vomiting, abdominal pain, decreased blood cell counts, and a tingling sensation. There are also risks of serious side effects such as intestinal perforation, bleeding, healing problems, blood clots (thrombi), and allergic reactions.", "Are there interactions with other medicines?": "You must inform your doctor if you are using other drugs, especially if you are taking sunitinib maleate, as the combination can cause serious effects. It is also important to inform them if you are receiving platinum-based or taxane-based treatments, or if you have recently received radiotherapy.", "What precautions should I take regarding my dental health?": "You must inform your doctor and dentist if you have pain, swelling, or sores in your mouth, or if you require invasive dental treatment, as the medicine can affect the health of the jawbone.", "What should I do if I am pregnant or planning to become pregnant?": "You must not use this medicine if you are pregnant, as it can harm the fetus. You must use contraceptive methods during treatment and for up to 6 months after the last dose. You should also not breastfeed during treatment or for up to 6 months after the last dose."}

    Form: solution for infusion, concentrate

    Active substance Dosage
    bevacizumab 400 mg

    ATC: L01F L01FG L01FG01

    Manufacturer: Amgen Technology (Ireland) Unlimited Company

  • It is used to treat various types of cancer in adults, including advanced colon or rectal cancer, metastatic breast cancer, advanced non-small cell lung cancer, advanced renal cancer, primary epithelial ovarian, fallopian tube, or peritoneal cancer, and persistent, recurrent, or metastatic cervical cancer.

    Form: solution for infusion, concentrate

    Active substance Dosage
    bevacizumab 25 mg

    ATC: L01F L01FG L01FG01

    Manufacturer: Stada Arzneimittel Ag

  • What is Vegzelma used for?": "It is used to treat adult patients with various types of cancer, including advanced colon or rectal cancer, metastatic breast cancer, advanced non-small cell lung cancer, advanced renal cancer, primary epithelial ovarian, fallopian tube, or peritoneal cancer, and persistent, recurrent, or metastatic cervical cancer.",

    Form: solution for infusion, concentrate

    Active substance Dosage
    bevacizumab 100 mg

    ATC: L01F L01FG L01FG01

    Manufacturer: Celltrion Healthcare Hungary Kft.

  • It is used to treat adult patients with various types of advanced cancer, including colorectal cancer (colon or rectum), metastatic breast cancer, advanced non-small cell lung cancer, kidney cancer, epithelial ovarian, Fallopian tube, or primary peritoneal cancer, and persistent, recurrent, or metastatic cervical cancer.

    Form: solution for infusion, concentrate

    Active substance Dosage
    bevacizumab 100 mg

    ATC: L01F L01FG L01FG01

    Manufacturer: Pfizer Europe Ma Eeig

  • It is used to treat adult patients with various types of advanced cancer, including colorectal cancer (colon or rectum), metastatic breast cancer, advanced non-small cell lung cancer, kidney cancer, epithelial ovarian, Fallopian tube, or primary peritoneal cancer, and persistent, recurrent, or metastatic cervical cancer.

    Form: solution for infusion, concentrate

    Active substance Dosage
    bevacizumab 400 mg

    ATC: L01F L01FG L01FG01

    Manufacturer: Pfizer Europe Ma Eeig